COP28

R&D

With the next global climate conference, COP28 in Dubai, having begun on 30th November, many businesses have been taking stock of their own record.

News

Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.